Detalles de la búsqueda
1.
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.
Cancer
; 130(10): 1784-1796, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38261444
2.
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study.
Lancet Oncol
; 24(1): 33-44, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36460017
3.
Spatial mapping of polymicrobial communities reveals a precise biogeography associated with human dental caries.
Proc Natl Acad Sci U S A
; 117(22): 12375-12386, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32424080
4.
Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection.
Ann Surg Oncol
; 29(2): 806-815, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34537899
5.
Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 study.
Invest New Drugs
; 40(5): 1051-1065, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35635631
6.
PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence.
Future Oncol
; 18(8): 903-913, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35073733
7.
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Lancet Oncol
; 22(12): 1692-1704, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34774225
8.
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
Lancet Oncol
; 22(6): 848-857, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34000246
9.
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 395(10240): 1835-1844, 2020 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32534646
10.
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
N Engl J Med
; 379(8): 722-730, 2018 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30134131
11.
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 379(4): 341-351, 2018 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29863979
12.
Melanoma Metastases to the Adrenal Gland Are Highly Resistant to Immune Checkpoint Inhibitors.
J Natl Compr Canc Netw
; 2021 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34348236
13.
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
Lancet Oncol
; 21(2): 294-305, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31952975
14.
Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trials.
J Transl Med
; 18(1): 294, 2020 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32746839
15.
Osteocyte calcium signals encode strain magnitude and loading frequency in vivo.
Proc Natl Acad Sci U S A
; 114(44): 11775-11780, 2017 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29078317
16.
Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM.
Br J Cancer
; 121(7): 522-528, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31417188
17.
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma.
Cancer Immunol Immunother
; 68(4): 609-618, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30721341
18.
A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
J Surg Oncol
; 120(7): 1276-1283, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31602665
19.
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up.
J Am Acad Dermatol
; 90(2): 414-418, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37839734
20.
Twist1 Inactivation in Dmp1-Expressing Cells Increases Bone Mass but Does Not Affect the Anabolic Response to Sclerostin Neutralization.
Int J Mol Sci
; 20(18)2019 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31505764